Advertisement
Journal Home
Search for

Volume 203, Issue 2, Pages 494-502 (April 2009)


View previous. 27 of 51 View next.

Ethnic and sex differences in circulating endotoxin levels: A novel marker of atherosclerotic and cardiovascular risk in a British multi-ethnic population

Michelle A. MilleraCorresponding Author Informationemail address, Philip G. McTernana, Alison L. Hartea, Nancy F. da Silvaa, Pasquale Strazzullob, K. George M.M. Albertic, Sudhesh Kumara, Francesco P. Cappuccioa

Received 14 March 2008; received in revised form 13 June 2008; accepted 13 June 2008. published online 31 July 2008.

Abstract 

Background

Circulating endotoxin levels are associated with atherosclerosis. Moreover, ethnic differences in pro-inflammatory markers may be associated with ethnic differences in atherosclerotic and cardiovascular (CVD) and coronary heart disease (CHD) risk.

Objective and methods

To investigate ethnic differences in circulating plasma endotoxin levels, its soluble receptor (sCD14), and high-sensitivity CRP (hs-CRP). 192 individuals, aged 40–59 years (61 white (30 women), 68 of African origin (33 women) and 63 South Asians (33 women)), free from coronary heart disease (CHD), stroke, CVD and diabetes were randomly selected from the UK ‘Wandsworth Heart and Stroke Study’.

Results

Age-adjusted endotoxin levels were lower in women than in men (p=0.002) and were highest in South Asians (13.3EU/mL [95% CI 12.0–14.7]) and lowest in individuals of African origin (10.1EU/mL [9.1–11.1]) than in whites (p for linear trend <0.001). Endotoxin levels were positively associated with waist, waist–hip ratio, total cholesterol, serum triglycerides and serum insulin levels and negatively associated with serum HDL-cholesterol. Serum hs-CRP and plasma sCD14 varied by ethnic group (p<0.001) but was not associated with endotoxin.

Conclusions

This study is the first to indicate a graded increase in endotoxin levels from black Africans to whites to South Asians, which is consistent with the ethnic difference in CHD risk. Whilst these findings support the concept that the innate immune system (IIS) may contribute significantly to the metabolic component underlying the development of CVD and CHD risk, further studies are required to see whether endotoxin levels are causally related to the development of CHD.

a Clinical Sciences Research Institute, Warwick Medical School, Coventry, UK

b Department of Clinical & Experimental Medicine, Federico II University, Naples, Italy

c Department of Endocrinology and Metabolism, St Mary's Hospital, Imperial College, London, UK

Corresponding Author InformationCorresponding author at: Clinical Sciences Research Institute, Clinical Sciences Building-UHCW Campus, Warwick Medical School, Clifford Bridge Road, Coventry CV2 2DX, UK. Tel.: +44 24 7696 8666; fax: +44 24 7696 8660.

PII: S0021-9150(08)00445-0

doi:10.1016/j.atherosclerosis.2008.06.018


View previous. 27 of 51 View next.

Advertisement